Alzheimer’s Disease Patent Issued to New Mexico Physicist Edward R. Flynn, Ph.D

ALBUQUERQUE, N.M. -- (BUSINESS WIRE) -- Senior Scientific, LLC announced today that it has been granted U.S. patent 8,060,179, titled “Biomagnetic Detection and Treatment of Alzheimer’s Disease”. The patent is for technology that will localize, and determine the amount, of plaque and neurofibrillary tangles in the brain, the principal characteristics of Alzheimer’s disease. Upon successful development of the technology, early and definitive localization of these effects of the disease by this method will discriminate against other types of treatable dementia while also providing a new method for delivery of treatment to remove these debilitating results of the disease.

The patent was granted for work by Dr. Edward R. Flynn, Ph.D., Founder and Chief Scientist of Senior Scientific, LLC and a Fellow of the Los Alamos National Laboratory.

Gerald Grafe, president of Senior Scientific, said, “Dr. Flynn has developed a new way of measuring disease in vivo. We plan to locate and quantify features of different diseases without the need for radioactive substances or high magnetic fields.” Grafe continued, “Using a highly sensitive magnetic system and nontoxic nanoparticles targeted to plaque and tangles, our technology will provide in-vivo detection of these plaques associated with the neurodegenerative disease commonly known as Alzheimer’s. We have patents pending on numerous aspects and applications of our core technology, and are pleased to have the patent related to Alzheimer’s disease issued.”

A copy of the patent abstract can be found at this link: http://patft.uspto.gov/

Website: www.SeniorScientific.com

Forward-looking statement

This press release contains forward-looking statements, which are subject to a number of risks, assumptions and uncertainties that could cause the Company's actual results to differ materially from those projected in such forward-looking statements. Management at Senior Scientific’s public parent company believes that purchase of the public parent company's shares (OTC BB: MHTX) should be considered to be at the high end of the risk spectrum. Forward-looking statements speak only as of the date made and are not guarantees of future performance. We undertake no obligation to publicly update or revise any forward-looking statements.

About Senior Scientific LLC

Senior Scientific LLC is focused on the rapidly emerging field of nanomedicine with an emphasis on the early detection and localization of cancer and other human diseases. Our technologies also hold the promise of providing image-guided therapy for the treatment of these diseases, as well as providing other new methods for therapeutic intervention.